Form 4: ProKidney Director and 10% Owner Reports Internal Share Exchange and Distribution

A recent SEC Form 4 filing reveals that Pablo G. Legorreta, a Director and 10% owner of ProKidney Corp., through his controlled affiliate Tolerantia, LLC, completed an exchange of paired interests for Class A Ordinary Shares, which were subsequently distributed to unaffiliated investors.

Summary

• Pablo G. Legorreta, a Director and 10% Owner of ProKidney Corp., along with Tolerantia, LLC, an affiliate controlled and majority-owned by Mr. Legorreta, filed a Form 4.
• On June 3, 2025, Tolerantia exchanged 3,823,996 Paired Interests (consisting of Common Units in ProKidney LP and an equal number of Class B Ordinary Shares) for 3,823,996 Class A Ordinary Shares.
• These exchanged Class A Ordinary Shares were then distributed in-kind pro rata to unaffiliated investors for no consideration.
• Prior to this transaction, 3,946,889 Paired Interests held by Tolerantia were attributable to these unaffiliated investors.
• The Class B Ordinary Shares and Common Units are paired securities, exchangeable for Class A Ordinary Shares on a one-for-one basis, as outlined in the Business Combination Agreement dated January 18, 2022.
• Following the reported transactions, Mr. Legorreta's indirect beneficial ownership of Class A Ordinary Shares decreased to 22,617,909, while his indirect beneficial ownership of Class B Ordinary Shares and Common Units in ProKidney LP decreased to 84,283,430 each.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing (Form 4) reporting an internal restructuring of ownership. It does not contain information that would typically be interpreted as positive or negative for the company's operational or financial performance, hence a neutral sentiment.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider's change in beneficial ownership, specifically an internal restructuring of equity interests. It does not provide information relevant to broader industry trends or competitive landscape analysis.

Related Party Transactions

• The transaction involves Tolerantia, LLC, an affiliate controlled and majority-owned by Pablo Legorreta, exchanging and distributing shares to unaffiliated investors, reflecting a restructuring of previously held interests.

Stakeholder Impact

• The primary impact is on the specific unaffiliated investors who received Class A Ordinary Shares as a result of the distribution, clarifying their direct ownership in ProKidney Corp.

Key Dates

Keywords

ProKidney Corp, PROK, SEC Form 4, Insider Transaction, Beneficial Ownership, Share Exchange, Class A Ordinary Shares, Class B Ordinary Shares, Common Units, Pablo Legorreta, Tolerantia LLC